# TherapeuticsMD, Inc.: Form 8-K/A, filed Jun 6, 2022

- Company: [TherapeuticsMD, Inc.](/companies/txmd.md) (CIK 25743)
- Form: 8-K/A
- Filed: 2022-06-06
- Accepted by EDGAR: Jun 6, 2022, 06:03 ET
- Period: 2022-05-27
- Accession: 0001564590-22-022527
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/25743/000156459022022527/txmd-8ka_20220527.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25743/000156459022022527/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/25743/000156459022022527/txmd-8ka_20220527.htm

Filed Jun 6, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-022527. Last ingested by Listed: Nov 14, 2026, 19:24 ET. No prices; not investment advice.
